Welcome to Liberty Case

We have a curated list of the most noteworthy news from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.

Subscribe to Liberty Case

Forever

Free

/ forever

Sign up with just an email address and you get access to this tier instantly.

Recommended

1-Year

$
300
$
0

/ year

Pay now and you get access to exclusive news and articles for a whole year.

1-Month

$
25
$
0

/ month

By agreeing to this tier, you are billed every month after the first one until you opt out of the monthly subscription.

Welcome to Liberty Case

We have a curated list of the most noteworthy news from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.

Welcome to Liberty Case

We have a curated list of the most noteworthy news from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.

No menu items!

Become a member

Get the best offers and updates relating to Liberty Case News.

― Advertisement ―

spot_img
HomeDestaquesDescobrir uma enzima chave abre possíveis avenidas terapêuticas para doenças lisossômicas

Descobrir uma enzima chave abre possíveis avenidas terapêuticas para doenças lisossômicas

  • Briefes de pesquisa

A reciclagem lipídica em organelas denominada lisossomos depende do BMP lipídico, que se pensava ser resistente à degradação por enzimas lisossômicas. Emerge que a enzima PLA2G15 quebra BMP e a inibição do PLA2G15 estende a vida útil em um modelo de camundongo do Niemann -Pick tipo C1, um distúrbio neurodegenerativo marcado pelo metabolismo lisossômico prejudicado.